Roche's End-to-End R Journey to Submission
Tuesday, September 10, 12:00pm - 1:00pm (EDT)
In the rapidly evolving landscape of pharmaceutical development, Roche showcases the use of open-source R in the regulatory submission process. In this webinar, the Roche team will share a pioneering experience of end-to-end R submission for a new drug application to the FDA, EMA, and NMPA.
They will unfold the journey of overcoming the initial challenges to achieving the filing goal and emphasize the practicalities of processing, analyzing, and visualizing clinical trial data in R, leading to a comprehensive eSubmission package.
They will also share our strategic communication and collaboration with regulatory agencies, highlighting how R-generated data and documentation were effectively presented and validated within the submission framework. The successful end-to-end NDA submission using R packages, the majority of which are open-source packages (from pharmaverse), not only demonstrates the feasibility and benefits of leveraging such a powerful tool in the regulatory realm but also sets a precedent for its wider adoption in the pharmaceutical industry.
Speakers:
Hinal Patel is a Principal Data Scientist at Roche. She is a project lead in analytical data science and has worked primarily on oncology molecule submissions. She was previously a product owner for admiralonco. She was an early adopter of Nextgen Tools & System and led a data science team to deliver end-to-end R submissions.
Ning Leng is the ad-interim Global Head of the Data Science Acceleration Enabling Platform, under Roche Product Development Data Sciences. Ning has been driving a number of internal and cross-industry projects on modernizing Data Science solutions in pharma.
Jingyuan Chen is a Principal Data Scientist in Roche, taking the positions of Project lead in Analytical Data Science and study statistician in oncology studies. In the end-to-end R filing project, she takes the role of data science filing lead.
More about Posit's work in Pharma: https://posit.co/solutions/pharma/
Watch Shifting to an Open-Source Backbone in Clinical Trials with Roche: https://www.youtube.com/watch?v=nqJsLSLd39A
You're going to "Roche's End-to-End R Journey to Submission".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
They will unfold the journey of overcoming the initial challenges to achieving the filing goal and emphasize the practicalities of processing, analyzing, and visualizing clinical trial data in R, leading to a comprehensive eSubmission package.
They will also share our strategic communication and collaboration with regulatory agencies, highlighting how R-generated data and documentation were effectively presented and validated within the submission framework. The successful end-to-end NDA submission using R packages, the majority of which are open-source packages (from pharmaverse), not only demonstrates the feasibility and benefits of leveraging such a powerful tool in the regulatory realm but also sets a precedent for its wider adoption in the pharmaceutical industry.
Speakers:
Hinal Patel is a Principal Data Scientist at Roche. She is a project lead in analytical data science and has worked primarily on oncology molecule submissions. She was previously a product owner for admiralonco. She was an early adopter of Nextgen Tools & System and led a data science team to deliver end-to-end R submissions.
Ning Leng is the ad-interim Global Head of the Data Science Acceleration Enabling Platform, under Roche Product Development Data Sciences. Ning has been driving a number of internal and cross-industry projects on...
---
Event details:
https://www.addevent.com/event/Ry22496273
https://www.youtube.com/live/BlJNILSoZlM false MM/DD/YYYY 30 OPAQUE aKHNCcebtzjkzVhQGmnG134315
You're interested in "Roche's End-to-End R Journey to Submission".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
They will unfold the journey of overcoming the initial challenges to achieving the filing goal and emphasize the practicalities of processing, analyzing, and visualizing clinical trial data in R, leading to a comprehensive eSubmission package.
They will also share our strategic communication and collaboration with regulatory agencies, highlighting how R-generated data and documentation were effectively presented and validated within the submission framework. The successful end-to-end NDA submission using R packages, the majority of which are open-source packages (from pharmaverse), not only demonstrates the feasibility and benefits of leveraging such a powerful tool in the regulatory realm but also sets a precedent for its wider adoption in the pharmaceutical industry.
Speakers:
Hinal Patel is a Principal Data Scientist at Roche. She is a project lead in analytical data science and has worked primarily on oncology molecule submissions. She was previously a product owner for admiralonco. She was an early adopter of Nextgen Tools & System and led a data science team to deliver end-to-end R submissions.
Ning Leng is the ad-interim Global Head of the Data Science Acceleration Enabling Platform, under Roche Product Development Data Sciences. Ning has been driving a number of internal and cross-industry projects on...
---
Event details:
https://www.addevent.com/event/Ry22496273
https://www.youtube.com/live/BlJNILSoZlM false MM/DD/YYYY 30 OPAQUE aKHNCcebtzjkzVhQGmnG134315
Thank you!
Your changes have been saved. Thanks for keeping us updated.
https://www.youtube.com/live/BlJNILSoZlM
Tyler Minear, tyler.minear@posit.co